ATE252644T1 - Für die endothellinie spezifisches transkriptions-regulatorelement aus tek - Google Patents

Für die endothellinie spezifisches transkriptions-regulatorelement aus tek

Info

Publication number
ATE252644T1
ATE252644T1 AT93918834T AT93918834T ATE252644T1 AT E252644 T1 ATE252644 T1 AT E252644T1 AT 93918834 T AT93918834 T AT 93918834T AT 93918834 T AT93918834 T AT 93918834T AT E252644 T1 ATE252644 T1 AT E252644T1
Authority
AT
Austria
Prior art keywords
endothelly
tek
specific
line
element made
Prior art date
Application number
AT93918834T
Other languages
English (en)
Inventor
Martin L Breitman
Daniel Dumont
Gerard G Gradwohl
Original Assignee
Mount Sinai Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital Corp filed Critical Mount Sinai Hospital Corp
Application granted granted Critical
Publication of ATE252644T1 publication Critical patent/ATE252644T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT93918834T 1992-08-25 1993-08-25 Für die endothellinie spezifisches transkriptions-regulatorelement aus tek ATE252644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/934,393 US5466596A (en) 1992-08-25 1992-08-25 Tissue specific transcriptional regulatory element
PCT/CA1993/000352 WO1994004694A1 (en) 1992-08-25 1993-08-25 Endothelial lineage specific transcriptional regulatory element from tek

Publications (1)

Publication Number Publication Date
ATE252644T1 true ATE252644T1 (de) 2003-11-15

Family

ID=25465497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918834T ATE252644T1 (de) 1992-08-25 1993-08-25 Für die endothellinie spezifisches transkriptions-regulatorelement aus tek

Country Status (7)

Country Link
US (1) US5466596A (de)
EP (1) EP0658209B1 (de)
JP (1) JPH08500247A (de)
AT (1) ATE252644T1 (de)
CA (1) CA2143336A1 (de)
DE (1) DE69333260D1 (de)
WO (1) WO1994004694A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08504760A (ja) * 1992-10-30 1996-05-21 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 新規なタンパク質チロシンキナーゼ
JPH10506011A (ja) * 1994-09-22 1998-06-16 ヘルシンキ、ユニバーシティ、ライセンシング、リミテッド、オサケ、ユキチュア レセプターチロシンキナーゼ、ｔｉｅのプロモーター
DE69733815T2 (de) 1996-02-15 2006-06-08 Biosense Webster, Inc., Diamond Bar Sonde zur exkavation
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
AU719629B2 (en) 1996-11-08 2000-05-11 Oklahoma Medical Research Foundation Endothelium specific expression regulated by EPCR control elements
DE19704301C1 (de) * 1997-02-06 1998-03-26 Hoechst Ag Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie
ES2255155T3 (es) 1998-02-05 2006-06-16 Biosense Webster, Inc. Dispositivo para la administracion intracardiaca de farmacos.
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
CA2565974A1 (en) * 2004-05-14 2005-12-01 Receptor Biologix, Inc. Cell surface receptor isoforms and methods of identifying and using the same

Also Published As

Publication number Publication date
DE69333260D1 (de) 2003-11-27
US5466596A (en) 1995-11-14
JPH08500247A (ja) 1996-01-16
CA2143336A1 (en) 1994-03-03
WO1994004694A1 (en) 1994-03-03
EP0658209A1 (de) 1995-06-21
EP0658209B1 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
ES2142801T3 (es) Clonacion y expresion de luciferasa de renilla.
ATE180404T1 (de) Hemmung des haarwachstums
ATE252644T1 (de) Für die endothellinie spezifisches transkriptions-regulatorelement aus tek
AR021974A1 (es) Promotor de s-adenosil-l-metionina sintetasa y su uso en la expresion de genes transgenicos en plantas
FR1308920A (fr) Filière d'extrusion
FR1439834A (fr) Utilisation nouvelle en cosmétologie d'un activateur cellulaire
CH387502A (fr) Installation pour l'emmagasinage et la fourniture d'informations sur des valeurs
GB1198337A (en) Photographic Materials containing Ultraviolet Light Absorbents
CH347730A (fr) Instrument d'écriture
FR1215297A (fr) Système d'alimentation électrique
GB1017132A (en) Improvements in or relating to information stores
BE611006A (fr) Système d'alimentation électrique
FR2209553A1 (en) Phosphorylated-cholines - as lipotropic, anti-steatosis antitoxic, choleretic and liver cell protecting agents
GB974748A (en) Improved telescope objectives
FR1270033A (fr) Système d'écriture phonétique
FR1220357A (fr) Régulateur pour systèmes d'alimentation électriques
FR1157390A (fr) Perfectionnements aux ornements d'oreilles
FR93907E (fr) Utilisation nouvelle en cosmétologie d'un activateur cellulaire.
ES262770A1 (es) Sistema econëmico-comercial para incrementar las ventas mediante cupones- "melodia"
GB858192A (en) Improvements in or relating to indicating and/or controlling instruments
FR1357370A (fr) Lettre d'ornementation
GR17091B (el) Επενδυσις τριχων δι' αδιαβροχου χρωματισμενου χαρτονιου.
ES233032U (es) Calendario portatil de sobremesa.
FR1194436A (fr) Perfectionnements concernant la production d'eau oxygénée
AU207104B2 (en) Improvements in or relating to injectors for use in oxygen regulators orthe like

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties